Exhibit 99.1

IASIS Healthcare Announces Second Quarter 2011 Results

FRANKLIN, Tenn.--(BUSINESS WIRE)--May 9, 2011--IASIS Healthcare® LLC (“IASIS”) today announced financial and operating results for the fiscal second quarter and six months ended March 31, 2011.

Net revenue for the second quarter totaled $678.4 million, an increase of 8.6%, compared to $624.5 million in the prior year quarter. Adjusted EBITDA for the second quarter totaled $78.1 million, compared to $79.6 million in the prior year quarter. Impacting adjusted EBITDA in the second quarter is $1.4 million in costs related to a one-time contract settlement and $600,000 in costs associated with the start-up of our physician professional liability captive insurance program. Net earnings from continuing operations for the second quarter totaled $22.3 million, compared to $22.1 million in the prior year quarter.

In the second quarter, admissions and adjusted admissions increased 7.0% and 10.8%, respectively, compared to the prior year quarter, while net patient revenue per adjusted admission increased 0.5%, compared to the prior year quarter. On a same-facility basis, excluding the impact of the Brim Holdings acquisition, admissions declined 0.9% and adjusted admissions increased 2.0%, each compared to the prior year quarter.

Net revenue for the six months ended March 31, 2011, totaled $1.35 billion, an increase of 7.8%, compared to $1.25 billion in the prior year period. Adjusted EBITDA for the six months ended March 31, 2011, totaled $146.4 million, compared to $151.4 million in the prior year period. Net earnings from continuing operations for the six months ended March 31, 2011, totaled $39.0 million, compared to $41.5 million in the prior year period.

For the six months ended March 31, 2011, admissions and adjusted admissions increased 5.4% and 9.3%, respectively, compared to the prior year period, while net patient revenue per adjusted admission increased 1.7%, compared to the prior year period. On a same-facility basis, admissions declined 2.6% and adjusted admissions increased 0.3%, each compared to the prior year period.

“We are excited about the future of our company,” said W. Carl Whitmer, president and chief executive officer of IASIS Healthcare. “To date, fiscal 2011 has been a year of transition and accomplishments, including the acquisitions of St. Joseph Medical Center and Brim Holdings and the recent completion of our refinancing transaction. We believe these events, along with our continued investment in physician alignment, quality and other operational and strategic growth initiatives, provide a solid foundation as we look to continue expanding our presence both regionally and nationally.”

A listen-only simulcast and 30-day replay of IASIS’ second quarter conference call will be available by clicking the “For Investors” link on the Company’s Web site at www.iasishealthcare.com beginning at 11:00 a.m. Eastern Time on May 9, 2011. A copy of this press release will also be available on the Company’s Web site.

IASIS, located in Franklin, Tennessee, is a leading owner and operator of medium-sized acute care hospitals in high-growth urban and suburban markets. The Company operates its hospitals with a strong community focus by offering and developing healthcare services targeted to the needs of the markets it serves, promoting strong relationships with physicians and working with local managed care plans. IASIS owns or leases 18 acute care hospital facilities and one behavioral health hospital facility with a total of 4,362 licensed beds and has total annual net revenue of approximately $2.8 billion. These hospital facilities are located in seven regions: Salt Lake City, Utah; Phoenix, Arizona; Tampa-St. Petersburg, Florida; five cities in Texas, including Houston and San Antonio; Las Vegas, Nevada; West Monroe, Louisiana; and Woodland Park, Colorado. IASIS also owns and operates a Medicaid and Medicare managed health plan in Phoenix that serves more than 195,000 members. For more information on IASIS, please visit the Company’s Web site at www.iasishealthcare.com.

Some of the statements we make in this press release are forward-looking within the meaning of the federal securities laws, which are intended to be covered by the safe harbors created thereby. Those forward-looking statements include all statements that are not historical statements of fact and those regarding our intent, belief or expectations including, but not limited to, future financial and operating results, the Company’s plans, objectives, expectations and other statements that are not historical facts. Forward-looking statements involve known and unknown risks and uncertainties that may cause actual results in future periods to differ materially from those anticipated in the forward-looking statements. These risk factors and uncertainties are more fully described in the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2010, and other filings with the Securities and Exchange Commission.

Although we believe that the assumptions underlying the forward-looking statements contained in this press release are reasonable, any of these assumptions could prove to be inaccurate, and, therefore, there can be no assurance that the forward-looking statements included in this press release will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, you should not regard the inclusion of such information as a representation by the Company or any other person that our objectives and plans will be achieved. We undertake no obligation to publicly release any revisions to any forward-looking statements contained herein to reflect events and circumstances occurring after the date hereof or to reflect the occurrence of unanticipated events.

Adjusted EBITDA represents net earnings from continuing operations before interest expense, income tax expense, depreciation and amortization, stock-based compensation, gain (loss) on disposal of assets and management fees. Management fees represent monitoring and advisory fees paid to TPG, the Company’s majority financial sponsor, and certain other members of IASIS Investment LLC. Management routinely calculates and communicates adjusted EBITDA and believes that it is useful to investors because it is commonly used as an analytical indicator within the healthcare industry to evaluate hospital performance, allocate resources and measure leverage capacity and debt service ability. In addition, the Company uses adjusted EBITDA as a measure of performance for its business segments and for incentive compensation purposes. Adjusted EBITDA should not be considered as a measure of financial performance under generally accepted accounting principles, and the items excluded from adjusted EBITDA are significant components in understanding and assessing financial performance. Adjusted EBITDA should not be considered in isolation or as an alternative to net earnings, cash flows generated by operating, investing, or financing activities or other financial statement data presented in the consolidated financial statements as an indicator of financial performance or liquidity. Adjusted EBITDA, as presented, differs from what is defined under the Company’s senior secured credit facilities and may not be comparable to similarly titled measures of other companies. A table describing adjusted EBITDA and reconciling net earnings from continuing operations to adjusted EBITDA is included in this press release in the attached Supplemental Consolidated Statements of Operations Information.

CONTACT:
IASIS Healthcare LLC
Investor Contact:
W. Carl Whitmer, 615-844-2747
President and Chief Executive Officer
or
John M. Doyle, 615-844-2747
Chief Financial Officer
or
Media Contact:
Michele M. Peden, 615-467-1255
VP, Corporate Communications